Treatment News : MSM Able to Use Home HIV Tests to Screen Sex Partners and Lower Risk - by Trenton Straube

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 25, 2012

MSM Able to Use Home HIV Tests to Screen Sex Partners and Lower Risk

by Trenton Straube

AIDS 2012Men who have sex with men and are at “high, high risk” of HIV can successfully use in-home rapid HIV tests to screen their sexual partners for the virus, according to a study involving a sample of this MSM population. The research, by Alex Carballo-Dieguez, PhD, and his colleagues at the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, was presented Tuesday, July 24, during an oral poster discussion at the XIX International AIDS Conference (AIDS 2012) in Washington, DC.

Participants in the study found the oral swab tests easy to use and “highly acceptable,” according to the researchers. The in-home tests helped these MSM identify high-risk partners—in fact, 10 men tested positive—and the tests helped the participants modify their own behavior so they were at lower risk of contracting HIV.

The topic of in-home HIV testing is no longer a hypothetical one. In July, the Food and Drug Administration approved the first such test, the OraQuick In-Home Rapid HIV test, which, according to the manufacturer OraSure, is expected to be available over the counter this October at “slightly more” than $17.50.

But would men who engage in high-risk sexual behavior—specifically, non-monogamous men who don’t use condoms when they have receptive anal sex with other men—be interested in testing their partners before hooking up? What would their motivations be? What problems—such as physical violence—could arise? In short, could the home tests be a successful harm-reduction technique?

To explore these topics, Carballo-Dieguez and his colleagues recruited 32 men in New York City to partake in a study. Each participant received 16 test kits to take home and use as an option. Carballo-Dieguez sought out men he characterized as “high, high risk”—they had multiple partners and reported never using condoms the last 10 times they had sex, or they had more than four partners in the past year and used condoms less than 80 percent of the time.

The average age of participants was 34. Forty-one percent were white, 33 percent were African American, and 19 percent were Latino. In the previous three months, participants had an average of 15 male sexual partners, 11 occasions of unprotected receptive anal intercourse and nine occasions of unprotected insertive anal intercourse. In addition, 48 percent had a lifetime history of sexually transmitted infections (STIs), 93 percent used alcohol in the previous three months, and 56 percent used marijuana during that same time period.

Before enrolling, participants performed a self-test using the home test in the researchers’ offices. During the three-month study period, they filed, via a phone system, weekly reports on their sexual behavior. And for the duration of the study, researchers set up a 24-hour hotline run by clinical psychologists.

Of the 32 men enrolled, 27 used the home tests to screen their partners. Of the nearly 140 sexual partners they encountered during the study period, 101 (72 percent) men agreed to take the home test,  23 (16 percent) men refused and 17 (12 percent) were not asked. The tests were used at home and, occasionally, in public.

Ten men tested positive for HIV; six of them did not know they were living with the virus. In addition, two partners disclosed that they were HIV positive once they were asked to take a home test. When a partner did test positive, the men did not have sexual intercourse. However, the researchers note, the participants did show empathy for their partners who tested positive.

There were four calls to the hotline, but Carballo-Dieguez said that all four calls were about clarifying the test results—for example, interpreting whether two lines meant a positive or negative reading.

He also noted that of the 124 partners asked to use the home test, there were seven instances of verbally aggressive reactions, but that no one resorted to physical violence.

In general, the researchers noted several other results: Participants liked having access to the home testing kits and found them easy to use, and they carried the kits around to various locations. Most partners were willing to take the test, and if they weren’t, the refusal was viewed as a warning sign. Often, mutual testing took place, and the period they waited for results gave them time to re-evaluate whether they really wanted to have unsafe sex. In most instances, substance abuse didn’t interfere with the home testing process. The tests had a high acceptability among ethnic minorities. And finally, participants said the experiences with home testing shifted their own awareness of HIV risk, which in turn led them to take fewer risks.

During the discussion period, audience members brought up concerns about using home testing to weed out HIV-positive sexual partners and thus lower risk. As one German conference delegate put it: “I remember a time when condom use was posed as a method to have sex with MSM without needing to know who was infected. Is that time over?”

“I think the [MSM] community is further ahead than we are as prevention workers,” Carballo-Dieguez replied. “Unfortunately we have a patronizing approach to people; we think we have to treat them like they’re fainting violets. These men are not! We have to catch up to where things are, and we have to empower people if we can.”

On the challenges of stigma and the window period—the highly infectious time shortly after a person contracts HIV but when the antibodies won’t show up on a home test—Carballo-Dieguez acknowledged that the home test isn’t 100 percent perfect. “When I talk about testing, I understand there is a risk for some people,” he said. “But it’s also an opportunity to empower people to put prevention in their own hands, and this is something people can do on their own. It’s technology that’s already available. It is something that can have an effect for some people—for certain people. If tools are there, we have to find a way to clarify [them]. For example, we can say, ‘This is how some people use [the test]. You make your choice.’ It is up to them.

“We are still giving people an efficient tool to screen [HIV risk],” he said. “Sometimes, because we want something that is optimal we don’t work with something that is good enough.”

In the written abstract of the study, the researchers conclude: “MSM at high risk can use [home tests] to screen sexual partners, and many partners will agree to take the test. Use of HT results in detection of previously unknown infections and avoidance of HIV exposure. Making [home tests] available within networks where high-risk sexual practices are common may be a cost-effective way to identify previously undetected cases. [Home tests] may become an important harm reduction technology.”

Search: home hiv testing, oraquick, orasure, sex partners, risk reduction, screening, aids 2012

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (29 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.